B. Braun has announced the availability of large volume heparin infusion solutions. P5671, Heparin Sodium (40 U/mL) in 5% Dextrose Injection (500 mL EXCEL Plastic Container) P5771, Heparin Sodium (50 ...
The FDA approved a taurolidine and heparin (DefenCath) catheter lock solution for reducing the risk of bloodstream infections in patients on dialysis. Approved under a special limited agency pathway, ...
Our own observations have suggested that different commercial preparations of heparin and different concentrations of the same brand of heparin may artificially elevate the blood ammonia concentration ...
This is the first FDA-approved antimicrobial catheter lock solution. The FDA has approved taurolidine plus heparin (DefenCath®) catheter lock solution to reduce catheter-related bloodstream infections ...
THE chief obstacles to the wide-scale use of heparin in the treatment of venous thromboembolic disease, are two: the expense of the available commercial heparin preparations and the transiency of ...
SCA Pharma set out to expand capacity for key drugs earlier this summer. Now, the compounding pharmacy is pulling one of its critical meds—common blood thinner heparin—from hospitals nationwide over ...
PURPOSE: To determine whether an antibiotic flush solution containing vancomycin, heparin, and ciprofloxacin (VHC) can prevent the majority of line infections. PATIENTS AND METHODS: A prospective ...
ON NOV. 19, 2007, St. Louis Children's Hospital noticed the first of several acute allergic reactions in children undergoing dialysis. The hospital reported the reactions to the Missouri Department of ...
B. Braun has announced the availability of large volume heparin infusion solutions. The following heparin infusion solutions are now available from B. Braun without restriction: P5671, Heparin Sodium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results